Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Myriad Pharmaceuticals, Inc. (MYRX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Myriad Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1459450.
Total stock buying since 2010: $2,052,692.
Total stock sales since 2010: $188,889.
Total stock option exercises since 2010: $48,100.
▪ Recent SEC 13D filings for all companies
▪ Funds & ETFs holding MYRX
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2013 | 0 | $0 | 0 | $0 | 32,500 | $48,100 |
| 2012 | 84,339 | $217,475 | 77,693 | $184,531 | 0 | $0 |
| 2011 | 441,170 | $1,133,466 | 0 | $0 | 0 | $0 |
| 2010 | 189,900 | $701,751 | 1,153 | $4,358 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2013-01 | 0 | $0 | 0 | $0 | 32,500 | $48,100 |
| 2012-11 | 0 | $0 | 77,000 | $182,910 | 0 | $0 |
| 2012-09 | 0 | $0 | 693 | $1,621 | 0 | $0 |
| 2012-06 | 9,141 | $21,408 | 0 | $0 | 0 | $0 |
| 2012-05 | 75,198 | $196,067 | 0 | $0 | 0 | $0 |
| 2011-12 | 101,010 | $271,995 | 0 | $0 | 0 | $0 |
| 2011-11 | 340,160 | $861,471 | 0 | $0 | 0 | $0 |
| 2010-12 | 16,817 | $62,220 | 0 | $0 | 0 | $0 |
| 2010-11 | 173,083 | $639,531 | 0 | $0 | 0 | $0 |
| 2010-06 | 0 | $0 | 1,153 | $4,358 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-01-18 | Henderson John T (Director) | Option Ex | 32,500 | 1.48 | 48,100 |
| 2012-11-02 | First Eagle Investment Management, Llc (10% Owner) | Sale | 42,000 | 2.38 | 99,960 |
| 2012-11-01 | First Eagle Investment Management, Llc (10% Owner) | Sale | 35,000 | 2.37 | 82,950 |
| 2012-09-25 | Kendell Andrea (Chief Financial Officer) | Sale | 693 | 2.34 | 1,621 |
| 2012-06-18 | Aryeh Jason (Director) | Buy | 3,000 | 2.29 | 6,879 |
| 2012-06-15 | Aryeh Jason (Director) | Buy | 1,025 | 2.35 | 2,408 |
| 2012-06-14 | Aryeh Jason (Director) | Buy | 4,000 | 2.36 | 9,448 |
| 2012-06-07 | Aryeh Jason (Director) | Buy | 1,116 | 2.40 | 2,673 |
| 2012-05-31 | Aryeh Jason (Director) | Buy | 10,133 | 2.35 | 23,772 |
| 2012-05-30 | Aryeh Jason (Director) | Buy | 4,020 | 2.46 | 9,909 |
| 2012-05-25 | Aryeh Jason (Director) | Buy | 153 | 2.47 | 377 |
| 2012-05-23 | Aryeh Jason (Director) | Buy | 1,000 | 2.47 | 2,470 |
| 2012-05-22 | Aryeh Jason (Director) | Buy | 262 | 2.46 | 644 |
| 2012-05-21 | Aryeh Jason (Director) | Buy | 12,000 | 2.50 | 30,060 |
| 2012-05-18 | Aryeh Jason (Director) | Buy | 7,168 | 2.60 | 18,615 |
| 2012-05-17 | Aryeh Jason (Director) | Buy | 3,832 | 2.61 | 10,001 |
| 2012-05-16 | Belle Gerald P. (Director) | Buy | 27,700 | 2.74 | 75,787 |
| 2012-05-15 | Belle Gerald P. (Director) | Buy | 8,930 | 2.74 | 24,432 |
| 2011-12-05 | Aryeh Jason (Director) | Buy | 30,792 | 2.75 | 84,801 |
| 2011-12-02 | Aryeh Jason (Director) | Buy | 27,600 | 2.69 | 74,299 |
| 2011-12-01 | Aryeh Jason (Director) | Buy | 42,618 | 2.65 | 112,895 |
| 2011-11-30 | Aryeh Jason (Director) | Buy | 9,900 | 2.60 | 25,789 |
| 2011-11-29 | Aryeh Jason (Director) | Buy | 91,800 | 2.58 | 236,660 |
| 2011-11-28 | Aryeh Jason (Director) | Buy | 64,805 | 2.55 | 165,511 |
| 2011-11-25 | Aryeh Jason (Director) | Buy | 41,956 | 2.51 | 105,267 |
| 2011-11-23 | Belle Gerald P. (Director) | Buy | 6,100 | 2.48 | 15,097 |
| 2011-11-23 | Aryeh Jason (Director) | Buy | 25,499 | 2.50 | 63,620 |
| 2011-11-22 | Belle Gerald P. (Director) | Buy | 34,200 | 2.48 | 84,645 |
| 2011-11-22 | Aryeh Jason (Director) | Buy | 53,700 | 2.47 | 132,639 |
| 2011-11-14 | Aryeh Jason (Director) | Buy | 9,700 | 2.64 | 25,608 |
| 2011-11-11 | Aryeh Jason (Director) | Buy | 2,500 | 2.65 | 6,635 |
| 2010-12-15 | First Eagle Investment Management, Llc (10% Owner) | Buy | 2,100 | 3.70 | 7,770 |
| 2010-12-08 | First Eagle Investment Management, Llc (10% Owner) | Buy | 3,734 | 3.70 | 13,815 |
| 2010-12-07 | First Eagle Investment Management, Llc (10% Owner) | Buy | 1,179 | 3.70 | 4,362 |
| 2010-12-02 | First Eagle Investment Management, Llc (10% Owner) | Buy | 100 | 3.69 | 369 |
| 2010-12-01 | First Eagle Investment Management, Llc (10% Owner) | Buy | 9,704 | 3.70 | 35,904 |
| 2010-11-26 | First Eagle Investment Management, Llc (10% Owner) | Buy | 139,503 | 3.70 | 516,161 |
| 2010-11-24 | First Eagle Investment Management, Llc (10% Owner) | Buy | 18,606 | 3.70 | 68,842 |
| 2010-11-23 | First Eagle Investment Management, Llc (10% Owner) | Buy | 8,074 | 3.66 | 29,550 |
| 2010-11-12 | First Eagle Investment Management, Llc (10% Owner) | Buy | 6,900 | 3.62 | 24,978 |
| 2010-06-16 | Gibbs Andrew (Vice President, Legal) | Sale | 1,153 | 3.78 | 4,358 |
Insider trading activities including stock purchases, stock sales, and option exercises of MYRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Myriad Pharmaceuticals, Inc. (symbol MYRX, CIK number 1459450) see the Securities and Exchange Commission (SEC) website.